Transforming Prostate Cancer Treatment with AI Technology
EDAP TMS SA, known for its leadership in robotic energy-based therapies, has partnered with Avenda Health to launch the world's first AI-assisted Focal One robotic high-intensity focused ultrasound (HIFU) procedures for prostate cancer treatment. This groundbreaking collaboration aims to improve treatment accuracy and customize approaches based on individual patient needs, leading to better outcomes in cancer care.
Unfold AI: An Innovative Solution
Central to this partnership is Avenda Health's Unfold AI, a state-of-the-art multi-modal decision support platform that has received approval from the U.S. Food and Drug Administration. This advanced technology equips surgeons with the ability to craft 3D maps of a patient's cancer, giving them a clear view of tumor size and location that isn’t visible otherwise. With these detailed insights, urologists can carry out ablations that preserve healthy tissue and reduce the risk of side effects.
Boosting Precision in Cancer Treatment
Dr. Wayne G. Brisbane, Assistant Professor of Urology at a well-respected university, pointed out that incorporating AI into prostate cancer diagnostics can effectively pinpoint the presence of tumor cells. Early procedures utilizing data from Unfold AI have shown that it can guide ablation methods, leading to improved cancer control and lower health risks for patients undergoing these treatments.
Upcoming Demonstrations and Collaborations
Building on their initial successes, EDAP and Avenda Health are preparing to showcase their innovative techniques at an exciting industry event. They will demonstrate simulated AI-assisted procedures at the upcoming Joint Meeting of the Focal Therapy Society and Society of Urologic Robotic Surgeons, underscoring their dedication to collaboration and knowledge sharing within the medical community.
Shared Objective: Enhancing Patient Outcomes
Both companies are united by a vision to elevate patient care through advanced technology. Shyam Natarajan, CEO of Avenda Health, highlighted that using Unfold AI in conjunction with Focal One will empower physicians to precisely target tumors, ensuring comprehensive removal of cancerous tissues. This partnership between two leading technologies endeavors to raise the bar in prostate cancer care.
EDAP TMS: A Pioneer in Therapeutic Ultrasound
EDAP TMS SA stands out in the global therapeutic ultrasound sector, particularly in creating minimally invasive medical devices. Their cutting-edge HIFU devices are tailored to address prostate cancer by enabling accurate and safe tissue ablation. The Focal One platform along with its proprietary software symbolizes considerable progress in prostate cancer treatment, providing essential solutions from diagnostics through to intervention.
About Avenda Health and EDAP TMS
Avenda Health is committed to personalizing prostate cancer care through sophisticated technology. Their deep learning methodologies produce detailed cancer maps that reveal hidden tumor characteristics, ultimately assisting healthcare providers in making informed treatment decisions.
EDAP TMS, dedicated to innovation, manufactures and promotes medical devices that utilize ultrasound technology to tackle various health challenges. The Focal One system combined with the ExactVu Micro-Ultrasound device establishes EDAP TMS as a comprehensive resource for prostate cancer diagnostics and treatment solutions.
Frequently Asked Questions
What is the significance of the EDAP and Avenda Health partnership?
This collaboration aims to transform prostate cancer treatment by incorporating AI technology, which enables more personalized and precise treatment options tailored to patients.
How does Unfold AI enhance cancer treatment?
Unfold AI generates 3D cancer maps specific to each patient, providing crucial insights into tumor locations and sizes, which helps in planning more effective treatments.
Where will the AI-assisted procedures be demonstrated?
EDAP and Avenda Health plan to showcase their AI-assisted procedures at the 2024 Joint Meeting of the Focal Therapy Society and Society of Urologic Robotic Surgeons.
What benefits do robotic HIFU procedures provide?
Robotic HIFU procedures are minimally invasive, customizable to meet each patient's needs, and allow for precise tumor ablation while protecting surrounding healthy tissue.
Who should I contact for more information about EDAP TMS?
If you need more information, you can contact Blandine Confort in Investor Relations at EDAP TMS by calling +33 4 72 15 31 50 or emailing bconfort@edap-tms.com.
